10-Q Filing

SWK Holdings Corp CIK: 1089907 Q1 2025

Filing Information

Form Type	10-Q
Accession Number	`0001628280-25-025955`
Period End Date	20250331
Filing Date	20250515
Fiscal Year	2025
Fiscal Period	Q1
XBRL Instance	swkh-20250331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 164 Income Statement 96 Cash Flow Statement 156 Stockholders Equity 36

Balance Sheet 164 line items

Line Item	Tag	Value	Unit	Period
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$13.20M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$13.20M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$13.90M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$13.90M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$11.25M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$11.25M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$8.79M	USD	Point-in-time
Financing receivable, allowance for credit loss excluding accrued interest	`FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest`	$8.79M	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par or stated value per share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.81M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.81M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.93M	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$5.79M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$5.79M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$4.68M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$4.68M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Assets held for sale, net (Note 4)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.40M	USD	Point-in-time
Assets held for sale, net (Note 4)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.40M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Assets held for sale, net (Note 4)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.41M	USD	Point-in-time
Assets held for sale, net (Note 4)	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$6.41M	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Finance receivables and related interest receivable held for sale (Note 4)	`TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup`	-	USD	Point-in-time
Finance receivables and related interest receivable held for sale (Note 4)	`TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup`	-	USD	Point-in-time
Finance receivables and related interest receivable held for sale (Note 4)	`TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup`	$33.99M	USD	Point-in-time
Finance receivables and related interest receivable held for sale (Note 4)	`TradeAndLoansReceivablesHeldForSaleNetNotPartOfDisposalGroup`	$33.99M	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par or stated value per share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.14M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.14M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.05M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.05M	USD	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.21M	shares	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$20.25M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$20.25M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$75.94M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$75.94M	USD	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.22M	shares	Point-in-time
Common stock, shares, issued (in shares)	`CommonStockSharesIssued`	12.22M	shares	Point-in-time
Finance receivables, net of allowance for credit losses of $8,785 and $11,249 as of March 31, 2025 and December 31, 2024, respectively	`NotesAndLoansReceivableNetNoncurrent`	$223.08M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $8,785 and $11,249 as of March 31, 2025 and December 31, 2024, respectively	`NotesAndLoansReceivableNetNoncurrent`	$223.08M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $8,785 and $11,249 as of March 31, 2025 and December 31, 2024, respectively	`NotesAndLoansReceivableNetNoncurrent`	$277.76M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $8,785 and $11,249 as of March 31, 2025 and December 31, 2024, respectively	`NotesAndLoansReceivableNetNoncurrent`	$277.76M	USD	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.22M	shares	Point-in-time
Common stock, shares, outstanding (in shares)	`CommonStockSharesOutstanding`	12.22M	shares	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`CollateralOnForeignCurrencyForwardContract`	$2.75M	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$580.00K	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$580.00K	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$455.00K	USD	Point-in-time
Marketable investments	`EquitySecuritiesFvNiCost`	$455.00K	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$22.22M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$22.22M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$23.48M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$23.48M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$4.25M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$4.25M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.76M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.76M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$4.37M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$4.37M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$610.00K	USD	Point-in-time
Warrant assets	`WarrantAssets`	$610.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$28.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$28.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$48.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$48.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.99M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.99M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.55M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$2.55M	USD	Point-in-time
Total assets	`Assets`	$331.26M	USD	Point-in-time
Total assets	`Assets`	$331.26M	USD	Point-in-time
Total assets	`Assets`	$332.24M	USD	Point-in-time
Total assets	`Assets`	$332.24M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.81M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.81M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.04M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.04M	USD	Point-in-time
Liabilities held for sale (Note 4)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.32M	USD	Point-in-time
Liabilities held for sale (Note 4)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.32M	USD	Point-in-time
Liabilities held for sale (Note 4)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.25M	USD	Point-in-time
Liabilities held for sale (Note 4)	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$1.25M	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	$1.50M	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	$1.50M	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	$3.35M	USD	Point-in-time
Deferred income	`ContractWithCustomerLiabilityCurrent`	$3.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.72M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.72M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$31.41M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$31.41M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$31.57M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredLongTermDebt`	$31.57M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$6.23M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$6.23M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	-	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	-	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$309.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$309.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$335.00K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$335.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$38.59M	USD	Point-in-time
Total liabilities	`Liabilities`	$38.59M	USD	Point-in-time
Total liabilities	`Liabilities`	$43.55M	USD	Point-in-time
Total liabilities	`Liabilities`	$43.55M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,222,522 and 12,213,599 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,222,522 and 12,213,599 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,222,522 and 12,213,599 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,222,522 and 12,213,599 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.13B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.13B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.13B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.13B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$279.89M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$279.89M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$292.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$292.67M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$288.69M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$288.69M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$280.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$280.31M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$332.24M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$332.24M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$331.26M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$331.26M	USD	Point-in-time

Income Statement 96 line items

Line Item	Tag	Value	Unit	Period
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$10.71M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$10.71M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$11.04M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$11.04M	USD	1 Quarter
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$279.00K	USD	1 Quarter
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$279.00K	USD	1 Quarter
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$963.00K	USD	1 Quarter
Pharmaceutical development	`RevenueFromContractWithCustomerExcludingAssessedTax`	$963.00K	USD	1 Quarter
Other	`OtherIncome`	$157.00K	USD	1 Quarter
Other	`OtherIncome`	$157.00K	USD	1 Quarter
Other	`OtherIncome`	$46.00K	USD	1 Quarter
Other	`OtherIncome`	$46.00K	USD	1 Quarter
Total revenues	`Revenues`	$11.36M	USD	1 Quarter
Total revenues	`Revenues`	$11.36M	USD	1 Quarter
Total revenues	`Revenues`	$11.83M	USD	1 Quarter
Total revenues	`Revenues`	$11.83M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-1.47M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-1.47M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$5.30M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$5.30M	USD	1 Quarter
Interest expense	`InterestExpenseOperating`	$1.13M	USD	1 Quarter
Interest expense	`InterestExpenseOperating`	$1.13M	USD	1 Quarter
Interest expense	`InterestExpenseOperating`	$1.26M	USD	1 Quarter
Interest expense	`InterestExpenseOperating`	$1.26M	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$758.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$758.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$530.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$530.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$514.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$514.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$19.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$19.00K	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$3.28M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$3.28M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$2.68M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$2.68M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$8.11M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$8.11M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$1.08M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$1.08M	USD	1 Quarter
Unrealized net loss on warrants	`UnrealizedGainLossOnDerivatives`	$-95.00K	USD	1 Quarter
Unrealized net loss on warrants	`UnrealizedGainLossOnDerivatives`	$-95.00K	USD	1 Quarter
Unrealized net loss on warrants	`UnrealizedGainLossOnDerivatives`	$-424.00K	USD	1 Quarter
Unrealized net loss on warrants	`UnrealizedGainLossOnDerivatives`	$-424.00K	USD	1 Quarter
Net loss on exercise and cancellation of warrants	`MarketableSecuritiesUnrealizedGainLoss`	$-143.00K	USD	1 Quarter
Net loss on exercise and cancellation of warrants	`MarketableSecuritiesUnrealizedGainLoss`	$-143.00K	USD	1 Quarter
Net loss on exercise and cancellation of warrants	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	1 Quarter
Net loss on exercise and cancellation of warrants	`MarketableSecuritiesUnrealizedGainLoss`	-	USD	1 Quarter
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	$-82.00K	USD	1 Quarter
Loss on sale of assets	`GainLossOnDispositionOfAssets1`	$-82.00K	USD	1 Quarter
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-105.00K	USD	1 Quarter
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-105.00K	USD	1 Quarter
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-231.00K	USD	1 Quarter
Net loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-231.00K	USD	1 Quarter
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	$1.73M	USD	1 Quarter
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	$1.73M	USD	1 Quarter
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	-	USD	1 Quarter
Realized gain on early payment of finance receivable	`GainLossOnSaleOfNotesReceivable`	-	USD	1 Quarter
Loss on revaluation of finance receivables held for sale	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Loss on revaluation of finance receivables held for sale	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Loss on revaluation of finance receivables held for sale	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$-3.73M	USD	1 Quarter
Loss on revaluation of finance receivables held for sale	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$-3.73M	USD	1 Quarter
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$87.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$87.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$313.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$313.00K	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$697.00K	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$697.00K	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.82M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.82M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$229.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$229.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.28M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.28M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.37	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.37	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.04	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.04	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.37	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.37	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.23M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.23M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.47M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.47M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.50M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.50M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.24M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.24M	shares	1 Quarter

Cash Flow Statement 156 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-1.47M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-1.47M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$5.30M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$5.30M	USD	1 Quarter
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$91.00K	USD	1 Quarter
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$91.00K	USD	1 Quarter
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$80.00K	USD	1 Quarter
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$80.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$248.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$248.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$262.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$262.00K	USD	1 Quarter
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$1.26M	USD	1 Quarter
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$1.26M	USD	1 Quarter
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$229.00K	USD	1 Quarter
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$229.00K	USD	1 Quarter
Unrealized net loss on warrants	`FairValueAdjustmentOfWarrants`	$95.00K	USD	1 Quarter
Unrealized net loss on warrants	`FairValueAdjustmentOfWarrants`	$95.00K	USD	1 Quarter
Unrealized net loss on warrants	`FairValueAdjustmentOfWarrants`	$424.00K	USD	1 Quarter
Unrealized net loss on warrants	`FairValueAdjustmentOfWarrants`	$424.00K	USD	1 Quarter
Net loss from exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	$143.00K	USD	1 Quarter
Net loss from exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	$143.00K	USD	1 Quarter
Net loss from exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	-	USD	1 Quarter
Net loss from exercise and cancellation of warrants	`NetRealizedGainOnExerciseOfWarrants`	-	USD	1 Quarter
Loss from sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss from sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss from sale of assets	`GainLossOnDispositionOfAssets1`	$-82.00K	USD	1 Quarter
Loss from sale of assets	`GainLossOnDispositionOfAssets1`	$-82.00K	USD	1 Quarter
Loss on revaluation of finance receivables held for sale	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Loss on revaluation of finance receivables held for sale	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Loss on revaluation of finance receivables held for sale	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$-3.73M	USD	1 Quarter
Loss on revaluation of finance receivables held for sale	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$-3.73M	USD	1 Quarter
Foreign currency transaction (gain) loss	`ForeignCurrencyTransactionGainLossUnrealized`	$-783.00K	USD	1 Quarter
Foreign currency transaction (gain) loss	`ForeignCurrencyTransactionGainLossUnrealized`	$-783.00K	USD	1 Quarter
Foreign currency transaction (gain) loss	`ForeignCurrencyTransactionGainLossUnrealized`	$558.00K	USD	1 Quarter
Foreign currency transaction (gain) loss	`ForeignCurrencyTransactionGainLossUnrealized`	$558.00K	USD	1 Quarter
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-105.00K	USD	1 Quarter
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-105.00K	USD	1 Quarter
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-231.00K	USD	1 Quarter
Loss on marketable investments	`MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-231.00K	USD	1 Quarter
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$1.49M	USD	1 Quarter
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$1.49M	USD	1 Quarter
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$837.00K	USD	1 Quarter
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$837.00K	USD	1 Quarter
Interest paid-in-kind	`PaidInKindInterestCapitzlied`	$478.00K	USD	1 Quarter
Interest paid-in-kind	`PaidInKindInterestCapitzlied`	$478.00K	USD	1 Quarter
Interest paid-in-kind	`PaidInKindInterestCapitzlied`	$186.00K	USD	1 Quarter
Interest paid-in-kind	`PaidInKindInterestCapitzlied`	$186.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$111.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$111.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$307.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$307.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$514.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$514.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$19.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$19.00K	USD	1 Quarter
Interest, accounts receivable and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.20M	USD	1 Quarter
Interest, accounts receivable and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.20M	USD	1 Quarter
Interest, accounts receivable and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.62M	USD	1 Quarter
Interest, accounts receivable and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.62M	USD	1 Quarter
Foreign currency forward contract	`IncreaseDecreaseInForeignCurrencyForwardContract`	$-409.00K	USD	1 Quarter
Foreign currency forward contract	`IncreaseDecreaseInForeignCurrencyForwardContract`	$-409.00K	USD	1 Quarter
Foreign currency forward contract	`IncreaseDecreaseInForeignCurrencyForwardContract`	$870.00K	USD	1 Quarter
Foreign currency forward contract	`IncreaseDecreaseInForeignCurrencyForwardContract`	$870.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$283.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$283.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-980.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-980.00K	USD	1 Quarter
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.19M	USD	1 Quarter
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.19M	USD	1 Quarter
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-872.00K	USD	1 Quarter
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-872.00K	USD	1 Quarter
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$1.50M	USD	1 Quarter
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$1.50M	USD	1 Quarter
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$1.85M	USD	1 Quarter
Deferred income	`IncreaseDecreaseInDeferredRevenue`	$1.85M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.43M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.43M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.28M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.28M	USD	1 Quarter
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$110.00K	USD	1 Quarter
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$110.00K	USD	1 Quarter
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	-	USD	1 Quarter
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	-	USD	1 Quarter
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	$258.00K	USD	1 Quarter
Sale of marketable investments	`ProceedsFromWarrantExercisesInvestingActivities`	$258.00K	USD	1 Quarter
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$446.00K	USD	1 Quarter
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$446.00K	USD	1 Quarter
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$10.00M	USD	1 Quarter
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$10.00M	USD	1 Quarter
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$32.68M	USD	1 Quarter
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$32.68M	USD	1 Quarter
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$9.36M	USD	1 Quarter
Repayment of finance receivables	`ProceedsFromRepaymentsOfAccountsReceivableSecuritization`	$9.36M	USD	1 Quarter
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$8.00K	USD	1 Quarter
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$8.00K	USD	1 Quarter
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$7.00K	USD	1 Quarter
Corporate debt securities principal payments	`RepaymentOfCorporateDebtSecurities`	$7.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$100.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$100.00K	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.18M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.18M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$22.70M	USD	1 Quarter
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$22.70M	USD	1 Quarter
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-12.35M	USD	1 Quarter
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-12.35M	USD	1 Quarter
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-6.23M	USD	1 Quarter
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-6.23M	USD	1 Quarter
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$999.00K	USD	1 Quarter
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$999.00K	USD	1 Quarter
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$867.00K	USD	1 Quarter
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$867.00K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-13.35M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-13.35M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-7.10M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-7.10M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$262.00K	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$262.00K	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$23.88M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$23.88M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.81M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.81M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.50M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.50M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.81M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$29.81M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.93M	USD	Point-in-time
Transfer of finance receivables and related interest receivable to held for sale	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	$33.99M	USD	1 Quarter
Transfer of finance receivables and related interest receivable to held for sale	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	$33.99M	USD	1 Quarter
Transfer of finance receivables and related interest receivable to held for sale	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	-	USD	1 Quarter
Transfer of finance receivables and related interest receivable to held for sale	`FinancingReceivableTransferToHeldForSaleValuationAllowanceExpense`	-	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$173.00K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$173.00K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$775.00K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$775.00K	USD	1 Quarter
Fair value of warrants received with investment in finance receivables	`FairValueOfWarrantsReceivedWithFinanceReceivables`	-	USD	1 Quarter
Fair value of warrants received with investment in finance receivables	`FairValueOfWarrantsReceivedWithFinanceReceivables`	-	USD	1 Quarter
Fair value of warrants received with investment in finance receivables	`FairValueOfWarrantsReceivedWithFinanceReceivables`	$253.00K	USD	1 Quarter
Fair value of warrants received with investment in finance receivables	`FairValueOfWarrantsReceivedWithFinanceReceivables`	$253.00K	USD	1 Quarter

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.22M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	12.22M	shares	Point-in-time
Beginning balance	`StockholdersEquity`	$279.89M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$279.89M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$292.67M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$292.67M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$280.31M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$280.31M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$307.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$307.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$111.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$111.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$867.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$867.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$999.00K	USD	1 Quarter
Repurchases of common stock in open market	`StockRepurchasedDuringPeriodValue`	$999.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.54M	USD	1 Quarter
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$468.00K	USD	1 Quarter
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.21M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.22M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	12.22M	shares	Point-in-time
Ending balance	`StockholdersEquity`	$279.89M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$279.89M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$292.67M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$292.67M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$288.69M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$280.31M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$280.31M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.